Deep tech and science early stage investments

2050 Capital is an early stage tech, deep tech and science investment syndicate. We invest in transformative and defensible innovation that impacts large fundamental sectors.

2050 Capital in Figures

  • 30+ Investments
  • 2 Unicorns
  • 75% Up-rounds
  • 1 Exit

Portfolio

Origin Sciences

Gastro-intestinal conditions diagnostics using genomic sequencing

Biofourmis

Personal predictive care enabled by ML

Neuroglee

Digital therapeutics for neurodegenerative diseases

Vaticle

Knowledge graph database and query language

Vauban

Fund formation and governance platform

Qoala

Insuretech platform

AMFG

Additive Manufacturing execution system & workflow automation software

Snyk

Open source security for developers

Hadean

OS for distributed compute environment

View All

News

Indonesian insurtech startup Qoala banks US$65M Series B led by Eurazeo’s Tara Reeves

E27, May 2022

Health AI Startup Biofourmis Hits $1.3 Billion Valuation With Series D Funding

Forbes, Apr 2022

Aquant raised $70 million in Series C funding

Business Wire, Oct 2021

Snyk raises $530 million on an $8.5 billion valuation

Techcrunch, Sep 2021

View All